币界网报道：Eyenovia's stock surged 56.78% following the announcement of a new Chief Investment Officer (CIO) with extensive experience in the cryptocurrency sector. The company, known for its innovative ophthalmic therapeutics, has signaled a strategic shift by bringing in a crypto-focused executive to lead its investment strategy. The newly appointed CIO, whose name was not disclosed, has a strong track record in blockchain investments and digital asset management, which has sparked investor optimism about Eyenovia's potential expansion into the crypto and Web3 space. Market analysts suggest this move could position Eyenovia to capitalize on emerging opportunities in decentralized finance (DeFi) and digital health technologies. The hiring decision reflects a growing trend among traditional firms to integrate blockchain expertise into their leadership teams, aiming to diversify revenue streams and enhance shareholder value. While the company has not yet detailed specific crypto-related initiatives, the market reaction indicates strong confidence in the CIO's ability to drive transformative growth. Eyenovia's shares closed at a record high, with trading volume significantly above average, underscoring heightened investor interest. The broader crypto community is closely watching this development, as it may signal increased institutional crossover between biotech and blockchain industries.